Medicines planning
47 results
Applied filters
Annual medicines planning publication, Prescribing Outlook
24 August 2026Our annual output ‘PO’ supports managed entry and budget planning for new medicines, new indications and medicines with loss of exclusivity in the NHS.
Using our annual medicines planning publication, Prescribing Outlook
14 August 2026Users should be aware of the constraints and assumptions in creating Prescribing Outlook, as well as their responsibilities for use.
Biosimilar and key generic medicines – September 2026 update
16 September 2026An update around biosimilar and key generic medicines to support system planning and mobilisation.
Biosimilar insulin: a primary care discussion
1 July 2026A discussion about the considerations of implementing biosimilar insulin in primary care.
Biosimilar and key generic medicines – June 2026 update
25 June 2026An update about biosimilar and key generic medicines to support system planning and mobilisation
New Medicines News
9 April 2026New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
The licence and supporting evidence for denosumab 120mg biosimilars
16 January 2026Denosumab 120mg biosimilars are licensed. Learn about indications, formulations, supporting evidence and differences.
The licence and supporting evidence for golimumab biosimilar
2 June 2026We highlight evidence for available golimumab biosimilar(s) and differences between the biosimilar(s) and the reference product (Simponi).
The licence and supporting evidence for denosumab 60mg biosimilars
24 April 2026Denosumab 60mg biosimilars are licensed. Learn about indications, formulations, supporting evidence and differences.
Preparing to use ranibizumab biosimilar
5 November 2025Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team